Use of acetyl l-carnitine in the therapeutic treatment of catara

Details Use of acetyl l-carnitine in the therapeutic treatment of catara Use of acetyl l-carnitine in the therapeutic treatment of catara

1989-11-14

1991-08-06

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514551, 514912, A61K 31205, A61K 3122

Patent

active

050378511

ABSTRACT:
The use is described of acetyl L-carnitine and its pharmacologically acceptable salts in the therapeutic treatment of cataract. The medicament may be administered orally or parenterally or be applied as a collyrium containing approximately 10%-15% w/v of acetyl L-carnitine.

Affiliated with

Also associated with

Rating

Use of acetyl l-carnitine in the therapeutic treatment of catara does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of acetyl l-carnitine in the therapeutic treatment of catara, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of acetyl l-carnitine in the therapeutic treatment of catara will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1987390